麝香保心丸抗心肌细胞缺氧-复氧损伤活性成分筛选

韩琳; 吕超; 李敏; 黄慧梅; 畅婉琳; 彭成成; 柳润辉

doi:10.3969/j.issn.1006-0111.2014.03.012

麝香保心丸抗心肌细胞缺氧-复氧损伤活性成分筛选

doi: 10.3969/j.issn.1006-0111.2014.03.012

1.
第二军医大学药学院, 上海 200433
2.
福建中医药大学药学院, 福建福州 350108
3.
上海交通大学药学院, 上海 200240

Screening of main active components against cardiomyocyte hypoxia/reoxygenation injury in shexiang baoxin Pill

1.
School of Pharmacy, Second Military Medical University, Shanghai 200433, China
2.
College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fujian 350108, China
3.
School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China

摘要: 目的建立原代心肌细胞缺氧-复氧模型,并对麝香保心丸及其20种血中活性成分进行抗缺氧-复氧损伤的活性筛选。方法取新生(1~3 d)SD乳鼠的心脏,建立原代心肌细胞的缺氧-复氧损伤模型,并采用四甲基偶氮唑盐(MTT)比色法进行麝香保心丸及其入血成分的活性筛选。结果麝香保心丸在50 μg/ml浓度下具有较好的保护原代心肌细胞缺氧-复氧损伤的作用;人参皂苷Rb1、人参皂苷Rb2、蟾毒灵和麝香酮具有较好的保护原代心肌细胞缺氧-复氧损伤的作用。结论麝香保心丸具有抗心肌细胞缺氧-复氧损伤的作用,人参皂苷Rb1、人参皂苷Rb2、蟾毒灵和麝香酮是其主要的有效成分。该研究为麝香保心丸深入的药效和机制研究奠定了基础。
- 麝香保心丸 /
- 心肌细胞 /
- 缺氧-复氧模型 /
- 活性成分筛选
Abstract: Objective To build hypoxia/reoxygenation injury model in cultured neonatal rat cardiomyocyte and screen active components from Shexiang Baoxin Pill (SBP) absorbed in blood against hypoxia/reoxygenation injury. Methods Cardiomyocytes were isolated and purified from hearts of neonatal Sprague Dawley rats(1~3 days old) and were used to build hypoxia/reoxygenation injury model. The components of SBP absorbed in blood were screened by methyl thiazolil tetracolium (MTT) colorimetic method. Results SBP showed significant protective effect against cardiomyocytes hypoxia/reoxygenation injury atthe concentration of 50 μg/ml. Ginsenoside Rb1, Rb2, bufalin and muscone of twenty components from SBP absorbed in blood also possessed significant protective effect against cardiomyocytes hypoxia/reoxygenation injury. Conclusion SBP have the protective activity against cardiomyocytes hypoxia/reoxygenation injury, and ginsenoside Rb1, Rb2, bufalin, muscone are the main active components of SBP. This experiment offered basis for further pharmacodynamics and mechanism study of SBP.
- Shexiang Baoxin Pill (SBP) /
- cardiomyocyte /
- hypoxia/reoxygenation model /
- screening of active components

[1]	车薇, 陈红英, 张淑珍. 麝香保心丸的临床应用研究进展[J]. 中国急救复苏与灾害医学杂志, 2008, 3(5): 307-309.
[2]	宋华. 麝香保心丸的药理研究与临床评价[J]. 中成药, 2002, 24(2): 131-133.
[3]	李修, 金胡珂, 吴国洪. 麝香保心丸治疗急性心肌梗死疗效观察[J]. 现代中西医结合杂志, 2012, 21(10): 1062-1063.
[4]	Xiang L, Jiang P, Zhan CS, et al. The serum metabolomic study of intervention effects of the traditional Chinese medicine Shexiang Baoxin pill and a multi-component medicine polypill in the treatment of myocardial infarction in rats[J]. Mol Biosyst, 2012, 8(9): 2434-2442.
[5]	Jiang P, Liu RH, Dou SS, et al. Analysis of the constituents in rat plasma after oral administration of Shexiang Baoxin pill by HPLC-ESI-MS/MS[J]. Biomed Chromatogr, 2009, 23(12): 1333-1343.
[6]	郭黎安,王淑萍, 向丽, 等. 气相色谱-质谱法定性分析麝香保心丸挥发性入血成分的研究[J]. 药学实践杂志, 2012,30(3): 207-210.
[7]	Grynberg A, Athias P, Degois M. Effect of change in growth environment on cultured myocardial cells investigated in a standardized medium[J]. In vitro Cell Dev Biol, 1986,22(1): 44-50.
[8]	张爽, 李红, 杨世杰. 蒺藜皂苷单体 B 对心肌细胞缺氧/复氧损伤的保护作用[J]. 中国药理学通报, 2010, 26(2): 208-212.
[9]	马青变, 高炜, 郭艳红, 等. 缺氧复氧诱导大鼠心肌细胞内质网应激反应[J]. 北京大学学报(医学版), 2005, 37(4): 386-388.
[10]	Kong HL, Wang JP, Li ZQ, et al. Anti-hypoxic effect of ginsenoside Rbl on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo[J]. Acta Pharmacol Sin, 2009, 30 (4): 396-403.
[11]	Kong HL, Li ZQ, Zhao YJ, et al. Ginsenoside Rb1 protects cardiomyocytes against CoCl₂-induced apoptosis in neonatal rats by inhibiting mitochondria permeability transition pore opening[J]. Acta Pharmacol Sin, 2010, 31 (6): 687-695.
[12]	Wu QB, Li HT, Wu Y, et al. Protective effects of muscone on ischemia-reperfusion injury in cardiac myocytes[J]. J Ethnopharmacol, 2011, 138 (1): 34-39.

[1]	吴若南, 叶爽, 李墨晨轩, 缪震元, 罗川. 冬凌草甲素磺酰脲衍生物的设计与抗炎活性研究 . 药学实践与服务, 2025, 43(7): 335-338, 352. doi: 10.12206/j.issn.2097-2024.202401048
[2]	关欣怡, 杨宇洁, 闻俊. 不同场景下芬太尼类新精神活性物质检测研究进展 . 药学实践与服务, 2025, 43(): 1-7. doi: 10.12206/j.issn.2097-2024.202308033
[3]	卢熠菲, 宋佳, 沈红霞, 赵庆杰. 新型苦参碱衍生物的设计合成与体外抗炎活性研究 . 药学实践与服务, 2025, 43(): 1-8. doi: 10.12206/j.issn.2097-2024.202503005
[4]	游飘雪, 陈兰, 施艺玮, 王辉, 晁亮, 洪战英. 脑胶质瘤微流控芯片模型的构建及中药半枝莲药效评价应用研究 . 药学实践与服务, 2025, 43(2): 59-66. doi: 10.12206/j.issn.2097-2024.202409034
[5]	陈灿昕, 缪竹威, 缪朝玉. 血小板特异性Metrnl基因敲除小鼠模型的构建与验证 . 药学实践与服务, 2025, 43(3): 117-123. doi: 10.12206/j.issn.2097-2024.202409031
[6]	杨延涛, 郁超, 张志航, 潘宇炯, 何晓锋, 林敬宇, 李明智, 孙佳烨, 徐敏. 基于网络药理学、分子对接技术及体外实验验证探究健复饮治疗勃起功能障碍的作用机制 . 药学实践与服务, 2025, 43(): 1-10. doi: 10.12206/j.issn.2097-2024.202407013
[7]	邵明聪, 陈虎博, 张懿丹, 李梓嫣, 王丽娜. 乌头煎剂对小鼠RAW264.7巨噬细胞活性和极化的影响 . 药学实践与服务, 2025, 43(7): 329-334. doi: 10.12206/j.issn.2097-2024.202505043
[8]	李惠萍, 陈璐, 张琪金, 黄宝康. 紫苏叶挥发油成分的生物合成、含量测定及生物活性研究进展 . 药学实践与服务, 2025, 43(): 1-6. doi: 10.12206/j.issn.2097-2024.202412058
[9]	张紫璇, 高苑, 张利, 李佳莉, 徐希科, 祖先鹏. 中药防治急性肺损伤的活性成分及其作用机制研究进展 . 药学实践与服务, 2025, 43(9): 421-426, 474. doi: 10.12206/j.issn.2097-2024.202404079
[10]	高兴, 赵凤平, 王文涛, 田巍, 郑灿辉, 陈新. 胡椒的化学成分及其生物活性研究 . 药学实践与服务, 2025, 43(7): 313-319. doi: 10.12206/j.issn.2097-2024.202308065
[11]	余小翠, 王习文, 张贵英, 徐君伟, 祝雨薇, 胡丹. 麝香接骨胶囊的HPLC特征图谱的研究及7种成分含量测定 . 药学实践与服务, 2025, 43(8): 395-399. doi: 10.12206/j.issn.2097-2024.202307059
[12]	段雅倩, 王旭, 唐高卿, 邵艳茹, 黄宝康. 莲子和莲子心生物碱成分及抗癌活性的比较分析 . 药学实践与服务, 2025, 43(9): 449-454. doi: 10.12206/j.issn.2097-2024.202407061
[13]	王鹏, 张争艳, 吴宗贵. 活心丸（浓缩丸）联合八段锦对急性心肌梗死合并心力衰竭介入术预后的影响 . 药学实践与服务, 2025, 43(7): 348-352. doi: 10.12206/j.issn.2097-2024.202308034
[14]	王鹏, 陈顺, 赵逸, 高守红, 王志鹏. 卡培他滨致小鼠手足综合征模型的建立及评价 . 药学实践与服务, 2024, 42(9): 385-388, 398. doi: 10.12206/j.issn.2097-2024.202308045
[15]	赖立勇, 夏天爽, 徐圣焱, 蒋益萍, 岳小强, 辛海量. 中药青蒿抗氧化活性的谱效关系研究 . 药学实践与服务, 2024, 42(5): 203-210, 216. doi: 10.12206/j.issn.2097-2024.202211012
[16]	王雪莲, 郑斯莉, 李志勇, 罗亨宇, 缪朝玉. 全身过表达人METRNL基因小鼠模型的构建与验证 . 药学实践与服务, 2024, 42(5): 198-202, 222. doi: 10.12206/j.issn.2097-2024.202311014
[17]	张广雨, 杜晶, 刘梦珍, 朱丹妮, 闫慧, 刘冲. 新斯的明与山莨菪碱联合应用对肺型氧中毒的保护作用及其机制的研究 . 药学实践与服务, 2024, 42(10): 433-438, 444. doi: 10.12206/j.issn.2097-2024.202310049
[18]	陈静, 何瑞华, 翁月, 徐熠, 刘静, 黄瑾. 基于网络药理学和分子对接技术探究定清片活性成分治疗白血病的作用机制 . 药学实践与服务, 2024, 42(11): 479-486. doi: 10.12206/j.issn.2097-2024.202401073
[19]	姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量. 巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
[20]	白学鑫, 陈玉平, 盛春泉, 武善超. 具核梭杆菌小分子抑制剂的筛选及其抗结直肠癌活性研究 . 药学实践与服务, 2024, 42(12): 503-507. doi: 10.12206/j.issn.2097-2024.202405009

点击查看大图

计量

文章访问数: 4143
HTML全文浏览量: 370
PDF下载量: 297
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

麝香保心丸抗心肌细胞缺氧-复氧损伤活性成分筛选

doi: 10.3969/j.issn.1006-0111.2014.03.012

Screening of main active components against cardiomyocyte hypoxia/reoxygenation injury in shexiang baoxin Pill

计量

麝香保心丸抗心肌细胞缺氧-复氧损伤活性成分筛选

doi: 10.3969/j.issn.1006-0111.2014.03.012

1. 第二军医大学药学院, 上海 200433

2. 福建中医药大学药学院, 福建福州 350108

3. 上海交通大学药学院, 上海 200240

English Abstract

Screening of main active components against cardiomyocyte hypoxia/reoxygenation injury in shexiang baoxin Pill

1. School of Pharmacy, Second Military Medical University, Shanghai 200433, China

2. College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fujian 350108, China

3. School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China

全文HTML

目录

留言板

麝香保心丸抗心肌细胞缺氧-复氧损伤活性成分筛选

doi: 10.3969/j.issn.1006-0111.2014.03.012

Screening of main active components against cardiomyocyte hypoxia/reoxygenation injury in shexiang baoxin Pill

计量

出版历程

麝香保心丸抗心肌细胞缺氧-复氧损伤活性成分筛选

doi: 10.3969/j.issn.1006-0111.2014.03.012

1. 第二军医大学药学院, 上海 200433 2. 福建中医药大学药学院, 福建 福州 350108 3. 上海交通大学药学院, 上海 200240

English Abstract

Screening of main active components against cardiomyocyte hypoxia/reoxygenation injury in shexiang baoxin Pill

1. School of Pharmacy, Second Military Medical University, Shanghai 200433, China 2. College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fujian 350108, China 3. School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China

全文HTML

目录

1. 第二军医大学药学院, 上海 200433

2. 福建中医药大学药学院, 福建福州 350108

3. 上海交通大学药学院, 上海 200240

1. School of Pharmacy, Second Military Medical University, Shanghai 200433, China

2. College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fujian 350108, China

3. School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China